Use of Technetium-99m-Labeled Lipophilic Complex of Methoxy-Isobutyl-Isonitrile and Iopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion

In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutyl-isonitrile (99mTc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with 99mTc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. 99mTc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD.